GoodRx Holdings, Inc. has recently disclosed a notable change in its shareholding structure. In a filing dated November 10, 2026, LSV Asset Management reported that it now holds 5.5% of the company’s Class A common stock. This acquisition is significant as it underscores the increasing interest in GoodRx, particularly in the context of the competitive landscape of the computer processing and data preparation industry.

Background

GoodRx Holdings, Inc. operates in the services sector, specifically under the classification of computer processing and data preparation (SIC 7374). The company is publicly traded on the Nasdaq under the ticker symbol GDRX. GoodRx has been a key player in providing consumers with access to affordable medications and has been navigating various challenges in the healthcare landscape.

What the Filing Says

According to the SEC filing (accession number 0001050470-26-000019), LSV Asset Management has beneficially owned a total of 5,868,895 shares of GoodRx, which includes 2,982,356 shares with sole voting power. The filing indicates that LSV Asset Management's clients have the right to receive or direct the receipt of dividends from these shares.

Impact

This acquisition may impact various stakeholders, including shareholders, employees, and competitors in the healthcare technology sector. With LSV Asset Management now holding a significant stake, it could influence corporate governance and strategic decisions at GoodRx. The presence of institutional investors like LSV may also enhance the company's credibility and attract further investments.

What's Next

The filing does not say what happens next.